Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases
Nephron · 16.06.2026 · 1-7
DOI: 10.1159/000553130 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nephron, online erschienen am 16.06.2026. Verfasst von Minami Matsumoto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kyoto University, Kyoto, Japan. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Lysozyme-associated nephropathy (LyN) is an underrecognized cause of kidney dysfunction, commonly associated with chronic myelomonocytic leukemia (CMML). Case Presentation: We present 2 cases of LyN with distinct clinical manifestations. In Case 1, an 80-year-old man with primary myelofibrosis developed progressive monocytosis, kidney dysfunction, proteinuria, and elevated serum and urinary lysozyme levels. Kidney biopsy revealed lysozyme-positive intracytoplasmic granules within proximal tubular cells, confirming the diagnosis of LyN. Notably, the progressive increase in the number of lysozyme-positive bone marrow cells may serve as an indicator of LyN activity. Treatment with hydroxycarbamide, a cytoreductive agent, and ruxolitinib, a Janus kinase inhibitor, successfully stabilized kidney function. In Case 2, a 63-year-old man with CMML developed acute kidney injury. Although the etiology of kidney dysfunction could not be determined during life, autopsy revealed diagnostic features of LyN. To further investigate LyN pathophysiology, we performed the first mass spectrometry-based proteomic analysis of proximal tubules in 2 cases. LyN samples showed marked lysozyme accumulation and upregulation of proteins involved in lysosomal system, lipid metabolism, cellular stress, and chronic inflammation. These findings suggest that chronic lysozyme overload disrupts intracellular homeostasis and contributes to kidney injury.
Conclusion
LyN is underdiagnosed as unexplained tubular damage or chronic kidney disease, highlighting the need for awareness of the clinicopathological features.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Kyoto University, Kyoto, Japan.
- Department of Nephrology, Kyoto University, Kyoto, Japan, syamamon@kuhp.kyoto-u.ac.jp.
- Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan.
- Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
- Department of Pathology, International University of Health and Welfare School of Medicine Atami Hospital, Shizuoka, Japan.
Zitieren
APA
Matsumoto, M., Yamamoto, S., Shinkawa, K., Matsubara, T., Takeda, J., Kitawaki, T., Arai, Y., Teramoto, Y., Minamiguchi, S., Kanetsuna, Y., Joh, K., Yamaguchi, Y., Kang, D., Honda, K., Mii, A., Shimizu, A., Ubara, Y., & Yanagita, M. (2026). Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases. Nephron, 1-7. https://doi.org/10.1159/000553130
Vancouver
Matsumoto M, Yamamoto S, Shinkawa K, Matsubara T, Takeda J, Kitawaki T, et al. Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases. Nephron. 2026:1-7. doi:10.1159/000553130
BibTeX
@article{Matsumoto2026,
author = {Matsumoto, Minami and Yamamoto, Shinya and Shinkawa, Kanna and Matsubara, Takeshi and Takeda, June and Kitawaki, Toshio and Arai, Yasuyuki and Teramoto, Yuki and Minamiguchi, Sachiko and Kanetsuna, Yukiko and Joh, Kensuke and Yamaguchi, Yutaka and Kang, Dedong and Honda, Kazuho and Mii, Akiko and Shimizu, Akira and Ubara, Yoshifumi and Yanagita, Motoko},
title = {Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases},
journal = {Nephron},
year = {2026},
pages = {1--7},
doi = {10.1159/000553130}
}
EUVIMED